Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidekazu Shirota

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Vaccine|November 28, 2009
FDA guidance on prophylactic DNA vaccines: analysis and recommendationsDennis M Klinman, Sven Klaschik, Debra Tross, et al.
Cancer Immunology, Immunotherapy : CII|July 23, 2017
IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse modelShuku-Ei Ito, Hidekazu Shirota, Yuki Kasahara, et al.
Annals of the New York Academy of Sciences|October 3, 2009
Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotidesDennis M Klinman, Debbie Tross, Sven Klaschik, et al.
Infection and Immunity|May 25, 2004
CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infectionShu-ichi Ito, Ken J Ishii, Hidekazu Shirota, et al.
Vaccine|March 2, 2010
Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvantsDennis M Klinman, Sven Klaschik, Koji Tomaru, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifsDennis M Klinman, Ihsan Gursel, Sven Klaschik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12Hidekazu Shirota, Kunio Sano, Noriyasu Hirasawa, et al.
Cancer Immunology Research|December 7, 2016
IL4 from T Follicular Helper Cells Downregulates Antitumor ImmunityHidekazu Shirota, Dennis M Klinman, Shuku-Ei Ito, et al.
Medical Molecular Morphology|November 10, 2024
Primary hepatic alpha-fetoprotein-producing neuroendocrine neoplasm harboring FGFR2 and TP53 mutations: a case report and literature reviewHirofumi Watanabe, Kodai Enda, Fumiyoshi Fujishima, et al.
Science Signaling|January 4, 2018
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancerYingjie Nie, Jiang He, Hidekazu Shirota, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Vaccine|November 28, 2009
FDA guidance on prophylactic DNA vaccines: analysis and recommendationsDennis M Klinman, Sven Klaschik, Debra Tross, et al.
Cancer Immunology, Immunotherapy : CII|July 23, 2017
IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse modelShuku-Ei Ito, Hidekazu Shirota, Yuki Kasahara, et al.
Annals of the New York Academy of Sciences|October 3, 2009
Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotidesDennis M Klinman, Debbie Tross, Sven Klaschik, et al.
Infection and Immunity|May 25, 2004
CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infectionShu-ichi Ito, Ken J Ishii, Hidekazu Shirota, et al.
Vaccine|March 2, 2010
Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvantsDennis M Klinman, Sven Klaschik, Koji Tomaru, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifsDennis M Klinman, Ihsan Gursel, Sven Klaschik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12Hidekazu Shirota, Kunio Sano, Noriyasu Hirasawa, et al.
Cancer Immunology Research|December 7, 2016
IL4 from T Follicular Helper Cells Downregulates Antitumor ImmunityHidekazu Shirota, Dennis M Klinman, Shuku-Ei Ito, et al.
Medical Molecular Morphology|November 10, 2024
Primary hepatic alpha-fetoprotein-producing neuroendocrine neoplasm harboring FGFR2 and TP53 mutations: a case report and literature reviewHirofumi Watanabe, Kodai Enda, Fumiyoshi Fujishima, et al.
Science Signaling|January 4, 2018
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancerYingjie Nie, Jiang He, Hidekazu Shirota, et al.
Pageof 9